Naseem Zojwalla - Net Worth and Insider Trading
Naseem Zojwalla Net Worth
The estimated net worth of Naseem Zojwalla is at least $353,863 dollars as of 2024-11-13. Naseem Zojwalla is the CHIEF MEDICAL OFFICER of Olema Pharmaceuticals inc and owns about 30,664 shares of Olema Pharmaceuticals inc (OLMA) stock worth over $353,863. Details can be seen in Naseem Zojwalla's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Naseem Zojwalla has not made any transactions after 2023-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Naseem Zojwalla
Naseem Zojwalla Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Naseem Zojwalla owns 1 companies in total, including Olema Pharmaceuticals inc (OLMA) .
Click here to see the complete history of Naseem Zojwalla’s form 4 insider trades.
Insider Ownership Summary of Naseem Zojwalla
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OLMA | Olema Pharmaceuticals inc | 2023-11-22 | Chief Medical Officer |
Naseem Zojwalla Latest Holdings Summary
Naseem Zojwalla currently owns a total of 1 stock. Naseem Zojwalla owns 30,664 shares of Olema Pharmaceuticals inc (OLMA) as of November 22, 2023, with a value of $353,863.
Latest Holdings of Naseem Zojwalla
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals inc | 2023-11-22 | 30,664 | 11.54 | 353,863 |
Holding Weightings of Naseem Zojwalla
Naseem Zojwalla Form 4 Trading Tracker
According to the SEC Form 4 filings, Naseem Zojwalla has made a total of 1 transactions in Olema Pharmaceuticals inc (OLMA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Olema Pharmaceuticals inc is the sale of 14,556 shares on November 22, 2023, which brought Naseem Zojwalla around $209,315.
Insider Trading History of Naseem Zojwalla
- 1
Naseem Zojwalla Trading Performance
Naseem Zojwalla Ownership Network
Ownership Network List of Naseem Zojwalla
Ownership Network Relation of Naseem Zojwalla
Naseem Zojwalla Owned Company Details
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
Naseem Zojwalla is the Chief Medical Officer of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include 10 percent owner Paradigm Biocapital Advisors Lp , director & Chief Technology Officer Cyrus Harmon , and director & President and CEO Sean Bohen .
Olema Pharmaceuticals inc (OLMA) Insider Trades Summary
Over the past 18 months, Naseem Zojwalla made 1 insider transaction in Olema Pharmaceuticals inc (OLMA) with a net sale of 14,556. Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 338,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 2,300,000 shares made by Paradigm Biocapital Advisors Lp .
In summary, during the past 3 months, insiders sold 0 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,048,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,245,932 shares were bought by its insiders, resulting in a net sale of 1,802,142 shares.
Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
Naseem Zojwalla Mailing Address
Above is the net worth, insider trading, and ownership report for Naseem Zojwalla. You might contact Naseem Zojwalla via mailing address: C/o Olema Pharmaceuticals, Inc., 512 2nd Street, 4th Floor, San Francisco Ca 94107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
